Copyright
©The Author(s) 2015.
World J Nephrol. May 6, 2015; 4(2): 277-286
Published online May 6, 2015. doi: 10.5527/wjn.v4.i2.277
Published online May 6, 2015. doi: 10.5527/wjn.v4.i2.277
Cirrhosis with ascites |
Serum creatinine > 1.5 mg/dL (133 μmol/L) |
Absence of shock |
Absence of hypovolemia as defined by no sustained improvement of renal function (creatinine decreasing to < 133 μmol/L) following at least 2 d of diuretic withdrawal (if on diuretics) and volume expansion with albumin at 1 g/kg per day up to a maximum of 100 g/d |
No current or recent treatment with nephrotoxic drugs |
Absence of parenchymal renal disease as defined by proteinuria < 0.5 g/d, no microhematuria (< 50 red cells/high powered field) and normal renal ultrasonography |
- Citation: Dundar HZ, Yılmazlar T. Management of hepatorenal syndrome. World J Nephrol 2015; 4(2): 277-286
- URL: https://www.wjgnet.com/2220-6124/full/v4/i2/277.htm
- DOI: https://dx.doi.org/10.5527/wjn.v4.i2.277